angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Angina is primarily caused by an imbalance between myocardial oxygen supply and demand, often due to coronary artery disease (CAD), where atherosclerotic plaques lead to narrowed coronary arteries, reducing blood flow to the heart muscle.

• Secondary mechanism: Endothelial dysfunction in the coronary arteries impairs the vessels' ability to dilate, further compromising oxygen delivery to the myocardium, especially during increased physical activity or stress when the heart's oxygen demand rises.

• Key complication: This mismatch in oxygen supply and demand can result in myocardial ischemia, manifesting as chest pain or discomfort, and if prolonged, may lead to myocardial infarction (heart attack).

Patient Profile

Demographics:

58-year-old male, office manager

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Dull, squeezing chest pain radiating to left arm, shortness of breath, fatigue, occasional dizziness

• Vital signs: Blood pressure 148/92 mmHg, Heart rate 96 bpm, Respiratory rate 22 breaths per minute, Temperature 98.6°F, Oxygen saturation 93% on room air

Section 1

As the healthcare team continues to assess the 58-year-old male patient, there is a noticeable change in his status. Despite initial interventions, including administration of nitroglycerin and supplemental oxygen, the patient's symptoms have not significantly improved. His chest pain persists, and his oxygen saturation remains at 93% on room air. His vital signs indicate a more concerning trend; his heart rate has increased to 104 bpm, and his blood pressure has risen to 158/98 mmHg. These changes suggest escalating myocardial oxygen demand that is not being met, raising concerns for potential myocardial ischemia.

The development of moderate complications becomes evident as further diagnostic tests reveal new findings. An ECG shows ST-segment depression in the inferolateral leads, indicative of subendocardial ischemia. Laboratory results return with elevated cardiac biomarkers, including troponin I, which is slightly above the normal range, suggesting myocardial injury. These findings necessitate prompt clinical reasoning to address the possible progression from stable angina to unstable angina or even an impending myocardial infarction.

In response to the changing clinical picture, the healthcare team considers escalating management strategies. The patient is transferred to a higher level of care for closer monitoring and potential interventions, such as IV nitroglycerin for better control of chest pain and possibly anticoagulant therapy to prevent thrombus formation. The nursing team prepares to educate the patient about the importance of medication adherence, risk factor modification, and potential lifestyle changes to prevent further cardiac events, ensuring a comprehensive approach to his evolving condition.

Section 2

As the patient is transferred to the cardiac intensive care unit, the healthcare team closely monitors his response to the new interventions. The administration of IV nitroglycerin begins, aiming to alleviate chest pain by reducing myocardial oxygen demand through vasodilation. Despite this, the patient's discomfort persists, and he reports a sensation of increasing pressure in his chest. His oxygen saturation remains stable at 93% on room air, but further assessment reveals a heart rate that has climbed to 112 bpm and blood pressure that fluctuates around 162/100 mmHg. These findings suggest that the myocardial ischemia may be progressing, necessitating a reevaluation of the treatment plan.

In addition to the cardiac monitoring, repeat laboratory tests show a further rise in troponin I levels, now moderately elevated, confirming ongoing myocardial injury. The patient's ECG continues to demonstrate ST-segment depression, and there is a concern for evolving unstable angina or a non-ST elevation myocardial infarction (NSTEMI). In light of these developments, the decision is made to initiate anticoagulant therapy with low molecular weight heparin to prevent further thrombus formation and potential myocardial infarction.

The nursing team plays a critical role in managing the patient's care and providing education. They emphasize the importance of medication adherence, especially regarding the newly introduced anticoagulant regimen, and discuss the potential side effects and signs of bleeding. The patient is encouraged to report any new symptoms immediately and is introduced to lifestyle modifications, such as dietary changes and smoking cessation, to reduce cardiovascular risk. The focus on patient education aims to empower him to participate actively in his care, setting the stage for a more stable recovery and prevention of future cardiac events.

Section 3

As the patient continues to be monitored in the cardiac intensive care unit, a new complication arises. Despite the interventions, the patient begins to exhibit signs of pulmonary congestion. His respiratory rate increases to 24 breaths per minute, and auscultation reveals bilateral crackles in the lower lung fields, suggesting fluid accumulation. His oxygen saturation, while previously stable, begins to drop to 89% on room air, prompting the initiation of supplemental oxygen therapy. These respiratory changes, coupled with a persistent elevation in blood pressure and heart rate, indicate a possible onset of heart failure due to increased myocardial stress and ischemia.

The healthcare team swiftly adjusts the treatment plan to address the evolving situation. Furosemide, a diuretic, is administered intravenously to reduce fluid overload and alleviate pulmonary congestion. The patient's fluid status is closely monitored, and strict input and output measurements are initiated to guide diuretic therapy and prevent dehydration or electrolyte imbalances. Meanwhile, the cardiologist evaluates the need for further invasive procedures, such as coronary angiography, to assess the extent of coronary artery disease and determine if revascularization might be necessary.

In response to these developments, the nursing team updates the patient's care plan to emphasize the importance of monitoring respiratory status and signs of heart failure. Education efforts are reinforced, focusing on recognizing symptoms of fluid overload and the importance of adhering to fluid restrictions. The patient is also encouraged to maintain an upright position as much as feasible to improve ventilation and alleviate dyspnea. By actively involving the patient in understanding these new developments, the healthcare team aims to stabilize his condition and prevent further complications, paving the way for potential surgical interventions if deemed necessary.

Section 4

As the healthcare team continues to monitor the patient's response to the newly implemented interventions, a change in his status becomes apparent. While the administration of furosemide successfully reduces pulmonary congestion, as evidenced by decreased crackles upon auscultation and improved oxygen saturation levels stabilizing at 94% with supplemental oxygen, new concerns arise. The patient begins to exhibit signs of increased fatigue and a slight decline in urine output, raising suspicions of impending renal strain. His blood pressure shows variability, with systolic readings fluctuating between 140 and 160 mmHg, despite ongoing antihypertensive therapy. Heart rate remains elevated, consistently above 100 beats per minute, indicating persistent sympathetic stimulation and myocardial demand.

Laboratory results reveal a mild elevation in serum creatinine, now at 1.8 mg/dL from a baseline of 1.2 mg/dL, suggesting a potential compromise in renal function possibly exacerbated by diuretic therapy. Electrolyte monitoring shows a decrease in potassium levels, recorded at 3.3 mEq/L, necessitating the initiation of potassium supplementation to prevent the risk of arrhythmias. In light of these findings, the healthcare team decides to adjust the diuretic regimen, reducing the dose of furosemide and increasing monitoring for signs of electrolyte imbalance and renal impairment.

In response, the nursing team intensifies its focus on assessing the patient's renal function and cardiovascular status, incorporating frequent monitoring of urine output and vital signs into the care plan. Patient education efforts are re-emphasized, highlighting the importance of reporting any new symptoms such as muscle weakness or palpitations, which could indicate worsening electrolyte imbalances. By maintaining a vigilant and adaptive approach, the healthcare team aims to optimize the patient’s hemodynamic stability and renal function, thereby minimizing complications and preparing for potential cardiac interventions.

Section 5

New Complications:

Despite the adjustments in the furosemide regimen and the initiation of potassium supplementation, the patient begins to exhibit further signs of clinical deterioration, reflecting an evolving complexity in his condition. Over the next 24 hours, the patient's urine output continues to decline, now averaging less than 20 mL per hour, signaling potential acute kidney injury. Correspondingly, his serum creatinine level rises further to 2.2 mg/dL, confirming worsening renal function. The patient also reports persistent fatigue and new-onset confusion, raising concerns about possible fluid and electrolyte imbalances or inadequate cerebral perfusion.

Clinically, the patient's blood pressure remains erratic, now with occasional systolic spikes exceeding 160 mmHg, while diastolic readings drop to the low 60s, suggesting a widening pulse pressure. His heart rate persists in the tachycardic range, hovering around 110 beats per minute. An ECG performed in response to these symptoms reveals new ST-segment depressions in the lateral leads, hinting at ongoing myocardial ischemia exacerbated by the imbalance in oxygen supply and demand. Concurrently, repeat electrolyte analysis shows persistent hypokalemia, with potassium levels stubbornly low at 3.1 mEq/L despite supplementation, indicating potential challenges with absorption or increased losses.

Faced with these new complications, the healthcare team deliberates further interventions to stabilize the patient's condition. This includes considering alternative diuretic strategies, such as switching to a potassium-sparing diuretic to mitigate electrolyte disturbances, and exploring additional cardiac imaging to evaluate the extent of coronary artery involvement. The multidisciplinary team, including nephrology and cardiology specialists, convenes to assess the underlying causes of the patient's deteriorating renal function and cardiovascular instability. This evolving situation underscores the critical need for precise clinical reasoning and timely intervention to prevent further escalation and guide the patient toward recovery.